Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis

Background and aims: Nonalcoholic steatohepatitis (NASH) has become one of the major causes of cirrhosis and liver failure. However, there are currently no approved medications for managing NASH. Our study was designed to assess the effects of ginkgetin on NASH and the involved mechanisms.Methods: W...

Full description

Bibliographic Details
Main Authors: Chaoyang Wang, Yaowei Bai, Tongqiang Li, Jiacheng Liu, Yingliang Wang, Shuguang Ju, Wei Yao, Bin Xiong, Guofeng Zhou
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2023.1267445/full
_version_ 1797666514468339712
author Chaoyang Wang
Yaowei Bai
Tongqiang Li
Jiacheng Liu
Yingliang Wang
Shuguang Ju
Wei Yao
Bin Xiong
Guofeng Zhou
author_facet Chaoyang Wang
Yaowei Bai
Tongqiang Li
Jiacheng Liu
Yingliang Wang
Shuguang Ju
Wei Yao
Bin Xiong
Guofeng Zhou
author_sort Chaoyang Wang
collection DOAJ
description Background and aims: Nonalcoholic steatohepatitis (NASH) has become one of the major causes of cirrhosis and liver failure. However, there are currently no approved medications for managing NASH. Our study was designed to assess the effects of ginkgetin on NASH and the involved mechanisms.Methods: We constructed a mouse model of NASH by high-fat diet for 24 weeks. The effects of ginkgetin on NASH were evaluated by histological study, Western blot, and biochemical analysis. RNA Sequencing (RNA-Seq) analysis was used to investigate the alteration in gene expression and signaling pathways at bulk and single-cell levels.Results: Administration of ginkgetin resulted in a marked improvement in hepatic lipid accumulation, inflammation, and fibrosis in the NASH model. And these results were supported by bulk RNA-Seq analysis, in which the related signaling pathways and gene expression were markedly downregulated. Furthermore, single-cell RNA-Seq (scRNA-Seq) analysis revealed that the effects of ginkgetin on NASH were associated with the reprogramming of macrophages, hepatic stellate cells, and endothelial cells. Especially, ginkgetin induced a marked decrease in macrophages and a shift from pro-inflammatory to anti-inflammatory phenotype in NASH mice. And the NASH-associated macrophages (NAMs), which emerge during NASH, were also significantly downregulated by ginkgetin.Conclusion: Ginkgetin exhibits beneficial effects on improving NASH, supported by bulk and single-cell RNA-Seq. Our study may promote pharmacological therapy for NASH and raise the existent understanding of NASH.
first_indexed 2024-03-11T19:59:30Z
format Article
id doaj.art-6ce827ff41324e61a33587ae5edaccc1
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-03-11T19:59:30Z
publishDate 2023-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-6ce827ff41324e61a33587ae5edaccc12023-10-04T09:45:20ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122023-10-011410.3389/fphar.2023.12674451267445Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysisChaoyang Wang0Yaowei Bai1Tongqiang Li2Jiacheng Liu3Yingliang Wang4Shuguang Ju5Wei Yao6Bin Xiong7Guofeng Zhou8Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Interventional Radiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaDepartment of Interventional Radiology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, ChinaDepartment of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, ChinaBackground and aims: Nonalcoholic steatohepatitis (NASH) has become one of the major causes of cirrhosis and liver failure. However, there are currently no approved medications for managing NASH. Our study was designed to assess the effects of ginkgetin on NASH and the involved mechanisms.Methods: We constructed a mouse model of NASH by high-fat diet for 24 weeks. The effects of ginkgetin on NASH were evaluated by histological study, Western blot, and biochemical analysis. RNA Sequencing (RNA-Seq) analysis was used to investigate the alteration in gene expression and signaling pathways at bulk and single-cell levels.Results: Administration of ginkgetin resulted in a marked improvement in hepatic lipid accumulation, inflammation, and fibrosis in the NASH model. And these results were supported by bulk RNA-Seq analysis, in which the related signaling pathways and gene expression were markedly downregulated. Furthermore, single-cell RNA-Seq (scRNA-Seq) analysis revealed that the effects of ginkgetin on NASH were associated with the reprogramming of macrophages, hepatic stellate cells, and endothelial cells. Especially, ginkgetin induced a marked decrease in macrophages and a shift from pro-inflammatory to anti-inflammatory phenotype in NASH mice. And the NASH-associated macrophages (NAMs), which emerge during NASH, were also significantly downregulated by ginkgetin.Conclusion: Ginkgetin exhibits beneficial effects on improving NASH, supported by bulk and single-cell RNA-Seq. Our study may promote pharmacological therapy for NASH and raise the existent understanding of NASH.https://www.frontiersin.org/articles/10.3389/fphar.2023.1267445/fullginkgetinnonalcoholic steatohepatitisNASHbulksingle cellRNA sequecing
spellingShingle Chaoyang Wang
Yaowei Bai
Tongqiang Li
Jiacheng Liu
Yingliang Wang
Shuguang Ju
Wei Yao
Bin Xiong
Guofeng Zhou
Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis
Frontiers in Pharmacology
ginkgetin
nonalcoholic steatohepatitis
NASH
bulk
single cell
RNA sequecing
title Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis
title_full Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis
title_fullStr Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis
title_full_unstemmed Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis
title_short Beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single-cell RNA sequencing analysis
title_sort beneficial effects of ginkgetin on improving nonalcoholic steatohepatitis characterized by bulk and single cell rna sequencing analysis
topic ginkgetin
nonalcoholic steatohepatitis
NASH
bulk
single cell
RNA sequecing
url https://www.frontiersin.org/articles/10.3389/fphar.2023.1267445/full
work_keys_str_mv AT chaoyangwang beneficialeffectsofginkgetinonimprovingnonalcoholicsteatohepatitischaracterizedbybulkandsinglecellrnasequencinganalysis
AT yaoweibai beneficialeffectsofginkgetinonimprovingnonalcoholicsteatohepatitischaracterizedbybulkandsinglecellrnasequencinganalysis
AT tongqiangli beneficialeffectsofginkgetinonimprovingnonalcoholicsteatohepatitischaracterizedbybulkandsinglecellrnasequencinganalysis
AT jiachengliu beneficialeffectsofginkgetinonimprovingnonalcoholicsteatohepatitischaracterizedbybulkandsinglecellrnasequencinganalysis
AT yingliangwang beneficialeffectsofginkgetinonimprovingnonalcoholicsteatohepatitischaracterizedbybulkandsinglecellrnasequencinganalysis
AT shuguangju beneficialeffectsofginkgetinonimprovingnonalcoholicsteatohepatitischaracterizedbybulkandsinglecellrnasequencinganalysis
AT weiyao beneficialeffectsofginkgetinonimprovingnonalcoholicsteatohepatitischaracterizedbybulkandsinglecellrnasequencinganalysis
AT binxiong beneficialeffectsofginkgetinonimprovingnonalcoholicsteatohepatitischaracterizedbybulkandsinglecellrnasequencinganalysis
AT guofengzhou beneficialeffectsofginkgetinonimprovingnonalcoholicsteatohepatitischaracterizedbybulkandsinglecellrnasequencinganalysis